This rise in FABP4, which correlates with the drop in blood glucose observed within the first day of life, may indicate an additional hormonal signal in the complex insulin counterregulatory endocrine network, aiming at preventing postnatal hypoglycemia (9, 10). The gene discussed is FABP4; the disease is Hypoglycemia.